In summary, these data suggest that in panglioma patients, LINC00632 and its most downregulated transcript variant, MDHDH, might serve as novel diagnostic markers, prognostic indicators and candidates for GBM suppressors. This evidence concerns the gene LINC00632 and glioblastoma.